John Macor

John is the Global Head of Integrated Drug Discovery at Sanofi. He has 35 years of drug discovery experience in big pharma with 20 years in CNS. He was the Chair of the MEDI Division of the ACS in 2015 and the co-inventor of two marketed drugs (Relpax® and Nurtec®) and several other clinical candidates (including sparsentan, zavegepant and LX-9211 currently in late clinical trials). John was inducted into the ACS MEDI Hall of Fame in 2014.